Quantcast

Latest drug discovery Stories

2014-08-29 16:24:04

-- Clinical and preclinical programs remain on track SAN DIEGO, Aug. 29, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), an emerging biopharmaceutical company, announced today that Santosh Vetticaden, Chief Medical Officer and Senior Vice President, will be leaving the Company, for personal reasons, in mid-September. Edwin L. Parsley, D.O., the Chief Medical Officer of Aires Pharmaceuticals, which Mast acquired earlier this year, will assume Dr. Vetticaden's former...

2014-08-29 08:24:27

Investor update call to be held Tuesday, September 2 VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 29, 2014 /PR Newswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial statements. The Company recently changed its fiscal year end to June 30th in order to facilitate an application to list its common stock on a national securities exchange in the timeliest manner possible. DelMar's...

2014-08-28 12:30:53

DENVER, Aug. 28, 2014 /PRNewswire/ -- Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials. Today, clinical trials target specific cancers, disease staging, and genetic mutations - which may be contributing factors for the cancer, in the first place. The challenge that the industry faces, is that this information may not be well known to the patient or even their...

2014-08-27 23:15:57

Corra Group is introducing a new system for drug testing that will allow its clients to order drug tests from a wide range of vendors and a greater number of collection sites. This will convenience clients and candidates alike. El Segundo, CA (PRWEB) August 27, 2014 Corra Group is providing a wide range of drug collection sites in order to accommodate the compliance needs of those in the healthcare industry. As the healthcare industry continues as one of the strongest growth sectors in...

2014-08-27 08:24:05

MarketOptimizer.org adds new clinical trial report "Fatty Liver Disease Global Clinical Trials Review, H2, 2014" to its store. DALLAS, Aug. 27, 2014 /PRNewswire-iReach/ -- "Fatty Liver Disease Global Clinical Trials Review, H2, 2014 provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site...

2014-08-26 16:24:34

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cell-based Assays: Technologies and Global Marketshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/stem_cells/cell_based_assays_technologies_global_markets.htmlREPORT HIGHLIGHTSBCC Research estimates that the global market for cell-based assays will increase at a compound annual growth rate (CAGR) of 12.4% over the next five years to reach $15.2 billion in 2015 and $21.6 billion by...

2014-08-25 16:25:47

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Tremor Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-2014.html Tremor Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Tremor Global Clinical Trials Review, H2, 2014" provides data on the Tremor clinical trial scenario. This report provides elemental information and data relating to...

2014-08-25 16:25:29

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Traumatic Pain Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2312345/Traumatic-Pain-Global-Clinical-Trials-Review-H2-2014.html Traumatic Pain Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Traumatic Pain Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Pain clinical trial scenario. This report provides...

Mimicking natural evolution
2014-08-25 03:30:03

Sarah Reed, University of Leeds A revolutionary new scientific method developed at the University of Leeds will improve the diversity of ‘biologically active molecules’, such as antibiotics and anti-cancer agents. The researchers, who reported their findings online Aug. 24 in the journal Nature Chemistry, took their inspiration from evolution in nature. The research may uncover new pharmaceutical drugs that traditional methods would never have found. “Nature produces some...

2014-08-23 23:01:03

MarketOptimizer.org adds “Cardiomyopathy Global Clinical Trials Review, H2, 2014” to its store. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Dallas, Texas (PRWEB) August 23, 2014 Cardiomyopathy (heart muscle disease) is the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnea (breathlessness) and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.